Molecular testing for cancers in the chest
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This study looks at the genetic changes (molecular analysis) in certain cancers of the chest. It may help doctors learn more about what drives these cancers and how they might be diagnosed or treated in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer in the chest (non-small cell lung cancer, small cell lung cancer, thymoma, thymic carcinoma, mesothelioma, or a carcinoma of unknown primary).
- You are 18 years old or older.
- A doctor must have proven your diagnosis by tissue testing (histology).
- You can understand the study and agree to sign a written consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
This study looks for specific genetic markers of lung cancer by testing tissue taken from a lung mass. It may help doctors detect and better understand lung cancer based on genetic clues.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This trial is part of a lung cancer network that uses genetic (DNA) testing to better understand and treat non-surgical lung cancer. You might be eligible if you have certain stages of non-small cell lung cancer and can consent to participate.
Hear when a new Thymus Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.